1. Third-Party Content
Our platform aggregates news from various third-party sources and provides automatically generated summaries and translations. The complete content is accessible via external links. We have no influence on the accuracy, completeness, or timeliness of this content.
2. No Liability for External Links
We link to external third-party websites. The operators of these linked pages are solely responsible for their content. At the time of linking, no illegal content was apparent. However, permanent monitoring of the content of linked pages is not reasonable without concrete evidence of a legal violation. If we become aware of any legal violations, we will remove the relevant links immediately.
3. No Warranty and Liability
We make no warranty for the correctness, completeness, or quality of the information provided. Liability for damages caused by the use of the information provided or by incorrect or incomplete content is excluded.
4. Copyright and Source Attribution
The content comes from publicly accessible RSS feeds and is the property of the respective providers. The copyrights remain with the respective publishers or authors.
5. Changes and Updates
This disclaimer can be modified at any time without separate announcement.
Last updated: March 04, 2025
Die von den Pharmakonzernen Eli Lilly und Boehringer Ingelheim abgesagten Investitionen sind nach Einschätzung des Instituts der Deutschen Wirtschaft ein deutlicher Warnschuss.